Back to Journals » ClinicoEconomics and Outcomes Research » Volume 14
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Singapore Healthcare System Perspective
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,704 | Dovepress* | 6,035+ | 370 | 6,405 | |
PubMed Central* | 669 | 185 | 854 | ||
Totals | 6,704 | 555 | 7,259 | ||
*Since 3 May 2022 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar